Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,389,628 papers from all fields of science
Search
Sign In
Create Free Account
Ospemifene
Known as:
Z-2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol
, Deamino-hydroxytoremifene
, 2-(P-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (1)
FC-1271a
Ospemifene 60 MG Oral Tablet [Osphena]
analogs & derivatives
Broader (1)
Tamoxifen
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy
Mariana S Sousa
,
M. Peate
,
S. Jarvis
,
M. Hickey
,
M. Friedlander
Therapeutic Advances in Medical Oncology
2017
Corpus ID: 21318459
There is increasing attention and concern about managing the adverse effects of adjuvant endocrine therapy for women with early…
Expand
Review
2015
Review
2015
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes?
N. Biglia
,
V. Bounous
,
L. Sgrò
,
M. D'Alonzo
,
S. Pecchio
,
R. Nappi
Clinical Breast Cancer
2015
Corpus ID: 22794934
2014
2014
The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy
R. Nappi
,
N. Panay
,
N. Bruyniks
,
C. Castelo-Branco
,
T. D. Villiers
,
J. Simon
Climacteric
2014
Corpus ID: 19615121
Abstract Objectives To explore clinically relevant differences in severity of vulvar and vaginal atrophy (VVA) in postmenopausal…
Expand
Review
2013
Review
2013
Profile of Ospemifene in the Breast
S. Berga
Reproductive Sciences
2013
Corpus ID: 5513908
Vulvar and vaginal atrophy (VVA) is a chronic, progressive medical condition prevalent among postmenopausal women, which produces…
Expand
Review
2012
Review
2012
An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis.
B. Komm
,
A. Chines
Maturitas
2012
Corpus ID: 3250841
Review
2012
Review
2012
Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review
O. Tan
,
K. Bradshaw
,
B. Carr
Menopause
2012
Corpus ID: 20646545
ObjectiveMenopause and its transition represent significant risk factors for the development of vulvovaginal atrophy-related…
Expand
Review
2012
Review
2012
Selective Oestrogen Receptor Modulators Decrease the Inflammatory Response of Glial Cells
M. Arévalo
,
Y. Diz-Chaves
,
María Santos-Galindo
,
M. Bellini
,
Luis M. Garcia-Segura
Journal of neuroendocrinology
2012
Corpus ID: 205346631
Neuroinflammation comprises a feature of many neurological disorders that is accompanied by the activation of glial cells and the…
Expand
2008
2008
Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells
Anu Kallio
,
Tao Guo
,
+5 authors
P. Härkönen
Molecular and Cellular Endocrinology
2008
Corpus ID: 40810526
Highly Cited
2007
Highly Cited
2007
Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro
Husheem Michael
,
P. Härkönen
,
P. Härkönen
,
L. Kangas
,
H. Väänänen
,
T. Hentunen
British Journal of Pharmacology
2007
Corpus ID: 19114172
Several selective oestrogen receptor modulators (SERMs) with oestrogen agonist effects in bone cells and without increased risk…
Expand
Review
2003
Review
2003
Pharmacokinetics of Selective Estrogen Receptor Modulators
Karla C. Morello
,
G. Wurz
,
M. Degregorio
Clinical Pharmacokinetics
2003
Corpus ID: 13003168
Selective estrogen receptor modulators (SERMs) are a class of compounds used to treat and prevent breast cancer and osteoporosis…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE